Modification of the anxiolytic action of 5-MT1A compounds by GABA-benzodiazepine agents in rats

被引:44
作者
Fernández-Guasti, A
López-Rubalcava, C
机构
[1] Ctr Invest & Estudios Avanzados, Dept Farmacol & Toxicol, Secc Terapeut Expt, Mexico City 14000, DF, Mexico
[2] Inst Mexicano Psiquiatria, Div Invest & Neurociencias, Mexico City, DF, Mexico
关键词
rat burying behavior; 5-HT1A ligands; flumazenil bicuculline; GABA-serotonin interactions;
D O I
10.1016/S0091-3057(97)00482-6
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
The general purpose of the present study was to analyze the possible interactions between the GABA-benzodiazepine and the serotonin systems in the mediation of the antianxiety actions of 5-HT1A compounds. The anxiolytic effect of buspirone (5 mg/kg), ipsapirone (5 mg/kg), indorenate (5 mg/kg), and 8-OH-DPAT (0.5 mg/kg) was established in the rat burying behavior test. Flumazenil (5 mg/kg), but not bicuculline (2.5 mg/kg), effectively counteracted the reduction in burying behavior produced by buspirone, ipsapirone, and 8-OH-DPAT. These same 5-HT1A compounds, at subthreshold doses, produced an important reduction in burying behavior when combined with diazepam (0.25 mg/kg). The effect of indorenate was not altered by any of the antagonists and, when combined with diazepam it produced large increases in burying behavior latency. Only buspirone alone and in combination with bicuculline or flumazenil impaired motor coordination as tested in the rota rod. Data are discussed on the bases of the interaction between the GABAergic and serotonergic systems, stressing species differences and variations due to the animal model of anxiety. (C) 1998 Elsevier Science Inc.
引用
收藏
页码:27 / 32
页数:6
相关论文
共 51 条
[1]   INCREASED 5-HT RELEASE MEDIATES THE ANXIOGENIC RESPONSE DURING BENZODIAZEPINE WITHDRAWAL - A REVIEW OF SUPPORTING NEUROCHEMICAL AND BEHAVIORAL EVIDENCE [J].
ANDREWS, N ;
FILE, SE .
PSYCHOPHARMACOLOGY, 1993, 112 (01) :21-25
[2]  
BARRETT JE, 1986, J PHARMACOL EXP THER, V238, P1009
[3]  
BENITEZKING G, 1991, DRUG DEVELOP RES, V23, P433
[4]   ANIMAL-MODELS FOR ANXIETY AND RESPONSE TO SEROTONERGIC DRUGS [J].
BROEKKAMP, CLE ;
BERENDSEN, HHG ;
JENCK, F ;
VANDELFT, AML .
PSYCHOPATHOLOGY, 1989, 22 :2-12
[5]   DIRECT EFFECTS OF INDORENATE AND 8-OH-DPAT ON THE BLOOD-PRESSURE OF PITHED RATS [J].
CASTILLO, C ;
IBARRA, M ;
TERRON, JA ;
VILLALON, CM ;
HONG, E .
DRUG DEVELOPMENT RESEARCH, 1994, 33 (01) :20-25
[6]   PHARMACOLOGICAL EVIDENCE FOR INTERACTIONS BETWEEN 5-HT(1A)RECEPTOR AGONISTS AND SUBTYPES OF ALPHA(1)-ADRENOCEPTORS ON RABBIT AORTA [J].
CASTILLO, C ;
IBARRA, M ;
MARQUEZ, JA ;
VILLALOBOSMOLINA, R ;
HONG, E .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 241 (2-3) :141-148
[7]   EFFECT OF DIAZEPAM ON FATE OF INTRACISTERNALLY INJECTED SEROTONIN-C-14 [J].
CHASE, TN ;
KATZ, RI ;
KOPIN, IJ .
NEUROPHARMACOLOGY, 1970, 9 (02) :103-&
[8]   PRELIMINARY-REPORT OF A SIMPLE ANIMAL BEHAVIOR MODEL FOR THE ANXIOLYTIC EFFECTS OF BENZODIAZEPINES [J].
CRAWLEY, J ;
GOODWIN, FK .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1980, 13 (02) :167-170
[9]   SEROTONIN DOES NOT MEDIATE ANXIOLYTIC EFFECTS OF BUSPIRONE IN THE FEAR-POTENTIATED STARTLE PARADIGM - COMPARISON WITH 8-OH-DPAT AND IPSAPIRONE [J].
DAVIS, M ;
CASSELLA, JV ;
KEHNE, JH .
PSYCHOPHARMACOLOGY, 1988, 94 (01) :14-20
[10]  
Fernandez-Guasti A., 1990, Behav Pharmacol, V1, P429